Literature DB >> 23358984

Evaluation of treatment benefit in Journal of Clinical Oncology.

Pamela J Goodwin, Karla V Ballman, Eric J Small, Stephen A Cannistra.   

Abstract

Mesh：

Year:  2013        PMID： 23358984     DOI： 10.1200/JCO.2012.47.6952

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

1.  Adherence to and uptake of clinical practice guidelines: lessons learned from a clinical practice guideline on chemotherapy concomitant with radiotherapy in head-and-neck cancer.

Authors:  S F Hall; J C Irish; R W Gregg; P A Groome; S Rohland
Journal:  Curr Oncol       Date:  2015-04       Impact factor: 3.677

2.  Impact of concurrent chemotherapy with radiation therapy for elderly patients with newly diagnosed glioblastoma: a review of the National Cancer Data Base.

Authors:  Jiayi Huang; Pamela Samson; Stephanie M Perkins; George Ansstas; Milan G Chheda; Todd A DeWees; Christina I Tsien; Clifford G Robinson; Jian L Campian
Journal:  J Neurooncol       Date:  2016-11-14       Impact factor: 4.130

3.  Publication of comparative effectiveness research has not increased in high-impact medical journals, 2004-2013.

Authors:  Laura L Hester; Charles Poole; Elizabeth A Suarez; Jane S Der; Olivia G Anderson; Kathryn G Almon; Avanti V Shirke; M Alan Brookhart
Journal:  J Clin Epidemiol       Date:  2017-02-08       Impact factor: 6.437

4.  Impact on Oncological Outcomes and Intent-to-Treat Survival of Resection Margin for Transplantable Hepatocellular Carcinoma in All-Comers and in Patients with Cirrhosis: A Multicenter Study.

Authors:  Chetana Lim; Claire Goumard; Margarida Casellas-Robert; Santiago Lopez-Ben; Laura Lladó; Juli Busquets; Chady Salloum; Maria Teresa Albiol-Quer; Ernest Castro-Gutiérrez; Olivier Rosmorduc; Cyrille Feray; Emilio Ramos; Joan Figueras; Olivier Scatton; Daniel Azoulay
Journal:  World J Surg       Date:  2020-06       Impact factor: 3.352

5.  Age, Neurological Status MRC Scale, and Postoperative Morbidity are Prognostic Factors in Patients with Glioblastoma Treated by Chemoradiotherapy.

Authors:  Clotilde Verlut; Guillaume Mouillet; Eloi Magnin; Joëlle Buffet-Miny; Gabriel Viennet; Françoise Cattin; Nora Clelia Billon-Grand; Emilie Bonnet; Stéphanie Servagi-Vernat; Joël Godard; Romain Billon-Grand; Antoine Petit; Thierry Moulin; Laurent Cals; Xavier Pivot; Elsa Curtit
Journal:  Clin Med Insights Oncol       Date:  2016-08-17

6.  Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence.

Authors:  C M Booth; I F Tannock
Journal:  Br J Cancer       Date:  2014-01-14       Impact factor: 7.640

7.  Radiotherapy plus temozolomide in elderly patients with glioblastoma: a "real-life" report.

Authors:  J Biau; E Chautard; E De Schlichting; G Dupic; B Pereira; A Fogli; M Müller-Barthélémy; P Dalloz; T Khalil; A F Dillies; X Durando; C Godfraind; P Verrelle
Journal:  Radiat Oncol       Date:  2017-12-06       Impact factor: 3.481
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.